
Tongee
Develops new medical technologies to treat various metabolic diseases.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
* | CNY100m Valuation: CNY1.0b | Series C | |
Total Funding | 000k |
Related Content
Tangji Medical is a healthcare company specializing in innovative treatments for metabolic diseases, including diabetes and liver conditions. The company operates in the medical and healthcare market, targeting patients suffering from chronic metabolic disorders. Tangji Medical's business model revolves around the development and commercialization of advanced medical treatments and systems, such as the gastric transfer arming system, aimed at improving patient outcomes and quality of life. Revenue is generated through the sale of these medical products and treatments, as well as through clinical trials and research collaborations. The company serves a global clientele, with a particular focus on markets with high prevalence of metabolic diseases. Tangji Medical is committed to ongoing research and development to bring cutting-edge solutions to the healthcare industry.
Keywords: metabolic diseases, diabetes, liver conditions, healthcare, medical treatments, chronic disorders, gastric transfer, pain relief, health recovery, clinical trials.